StockDuty ← Dashboard Aug 17, 2026 05:58 AM ET
SignalFDA/Bio

Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

Phase 3 completion milestone signals pivotal trial data catalyst for chronic low back pain.

Phase 3 completion milestone signals pivotal trial data catalyst for chronic low back pain.
Sources